Introduction
It is widely accepted that neoplasms in epithelial organs arise via multiple intermediate stages (1) (2) (3) . This concept has been extensively developed over the past 30 years and is based upon both clinical and experimental observations in practically all major epithelial organs. The intermediate stages have been labeled with various terms, although the terms preneoplastic or premalignant have been used most frequently. It is the aim of this commentary to discuss the preneoplastic state in the mouse mammary gland. It is hoped that the review will invite discussion and comment, stimulate new ideas and experimental approaches, and attract new participants into this research area. The time is appropriate for such a review in light of the new methodologies which have been developed in the area of mammary gland research over the past 10 years and the opportunity to apply newer molecular biology approaches to examine basic questions in mammary carcinogenesis.
The model system
The biological properties of the preneoplastic state in the mouse mammary gland were characterized by DeOme and his coworkers (4-6) and have been extensively reviewed (7) (8) (9) . The most extensively characterized preneoplastic lesions are the hyperplastic alveolar nodules (HAN*). HAN represent transformed cell populations morphologically similar to the differentiated alveolar cells normally found in the pregnant mammary gland. These lesions are termed preneoplastic because they have been shown to exhibit a greater probability for tumor formation than their normal cell homologues, the alveoli found in pregnant mice (4, 7) . A second common preneoplastic lesion found in mice are ductal hyperplasias (DH). These lesions are induced by chemical carcinogens (8, 10) , and by some hormone treatments (11,12). In chemical-carcinogen-treated mice, DH develop during the first 6-9 months after exposure, whereas HAN tend to develop later (10, 13) . DH, like HAN, give rise to mammary adenocarcinomas upon transplantation into syngeneic mice. A curiosity about DH is their tendency to develop into mixed ductal -alveolar hyperplasias upon serial transplantation or to lose their capacity for transplantability (14) . In one case, the morphological progression from ductal to alveolar hyperplasia was correlated with a change from a low to a high tumor potential (15) . The majority of the information on mammary preneoplasias has been obtained with HAN, thus the focus of this article will emphasize HAN and their derivative hyperplastic outgrowth lines. The scheme shown in Figure 1 illustrates the basic sequence of events in mammary tumorigenesis.
Agents, such as the mammary tumor viruses (MMTV), chemical carcinogens [dimethylbenzanthracene (DMBA) and urethane] and prolonged hormonal stimulation induce HAN (step 1). Individual HAN transplanted into mammary-gland-free fat pads of syngeneic mice will grow and fill the fat pad with mammary alveolar cells (step 3). These transplants are termed preneoplastic hyperplastic outgrowth lines and abbreviated as HOG or HPO. The outgrowth lines can be perpetuated by serial transplantation into the 'cleared' mammary fat pads every 8 -12 weeks. Such HOG lines have been developed from HAN induced by MMTV (4, 5) , DMBA (13) , hormones (7) , and cells transformed in cell culture by DMBA (16) or spontaneously (15) .
The preneoplastic outgrowth lines, like their progenitor primary HAN, and the DH (step 2), have increased probabilities for tumor formation (step 4). In the absence of additional exposure to MMTV, chemical carcinogens or high levels of hormones, the HOG lines produce mammary tumors at a rate characteristic for each line. The tumor-producing capabilities (% tumors at 12 months after transplantation) of the different lines extend over a wide range from low (CS6 < 20, DID = 30, C4 = 30) to very high (D2 > 70, DIM-1 > 90). The additional exposure to MMTV, chemical carcinogens or certain drugs increases the tumor potential significantly (7), whereas certain hormones (17) decrease their tumor potential. The response to chemical carcinogens is dissimilar to that of liver nodules. The latter cell populations are postulated to be resistant to the subsequent effects of chemical carcinogens (2) . In a similar vein, the levels of phase 1 and phase 2 metabolic enzymes exhibit dissimilar patterns between mammary and liver preneoplastic cell populations (G. Batist and D.Medina, unpublished observations).
Essential alterations in mouse mammary transformation
The biological properties of the HOG lines have been described in detail. The examination of the growth properties of mammary preneoplasias in vivo has provided important information on the regulation of their growth potential. At least two essential alterations in -regulation of growth occur during the development of mammary tumors: one, the acquisition of immortality, occurs at the preneoplastic stage; the second, the acquisition of autonomy (here defined as freedom from local environmental factors which regulate growth), occurs at the neoplastic stage. With respect to the first alteration preneoplastic cells, unlike normal cells, are immortal. That is to say, the preneoplastic cells can be serially transplanted indefinitely. Some lines have been serially transplanted for over 20 years. Over this time, the morphological and tumorigenic properties remain relatively stable although several reports have documented marked alterations in these biological properties in specific outgrowth lines (15, 18, 19) . Normal mammary cells exhibit a finite life span and are no longer transplantable after five to seven serial transplants in vivo (20) . It is of interest that immortality in vivo does not translate into immortality in vitro. So far, no in vitro assay that reflects in vivo immortality or altered growth potential has been described for mammary epithelial cells (21) . For instance, preneoplastic, like normal cells, are not easily subculturable, do not grow in anchorage-independent conditions, do not exhibit cytochalasin-/3-induced multinucleation, do not exhibit altered Ca 2 + dependency, and do not exhibit unique lectin-binding sites (21) . The molecular basis for the new in vivo growth property is not understood; however, all HOG lines examined exhibit the property.
With respect to the second alteration, preneoplastic cells, like normal cells, are dependent upon undefined local factors which regulate growth and spatial distribution. The best examples of this regulation are observed in the dependence of the preneoplastic cells upon the fat pad stroma for proliferation and tumor transformation and the inability of preneoplastic cells to overgrow normal mammary ducts. Tumor cells have escaped this type of growth regulation. This property of autonomy represents the most fundamental alteration observed between preneoplastic and tumor cells. Thus, the essential differences between normal and neoplastic mammary cells are narrowed to two. The acquisition of immortality is viewed as the ability to express an indefinite division potential. For some reason the cell population does not senesce. The preneoplastic cell populations behave as if cells have a low probability of entering a G o terminal stage, but given the opportunity, will progress in the cell cycle through G] -S. The relevant alteration in gene expression has not been identified but these cell populations provide an excellent source to examine this question. However, it is clear that this change is not sufficient for tumorigenesis. The second change, which is expressed as a refractoriness to local growth factors, is necessary for tumorigenesis. Both alterations are probably important for expression of the tumorigenic phenotype, although perhaps not obligatory. I have argued that the induction of immortality (abrogation of senescence) allows the expansion of a cell population (22) . The sustained hyperplasia, maintained by an abrogation of senescence and a lack of terminal differentiation (post-mitotic differentiation), provides a large population for a prolonged time period (into the second year of life when the normal mammary gland is aging) which increases the risk of a second critical event. Thus, it is not surprising that both strong and weak oncogenic MMTV can neoplastically transform mammary preneoplasias at a very high rate, in contrast to their effect on normal virgin mammary tissue. Similarly, chemical carcinogens, such as DMBA and urethane, and irradiation are more effective oncogens for mammary preneoplasias than for normal virgin or pregnant mammary tissues.
The recent demonstration that several growth factors/inhibitors exhibit specific roles in mammary gland morphogenesis offers the hope that regulation of one of these factors may underlie the observed changes in in vivo growth potential. Silberstein and Daniel (23) have demonstrated that transforming growth factor (TGF)-/3 inhibits the proliferative activity of the mammary end buds. This observation is intriguing in light of the recent reports on the role of TGF-/3 in epithelial growth and differentiation.
TGF-/8 inhibits the growth of preneoplastic tracheal epithelial cells (24) , regulates normal differentiation of respiratory epithelium (25) and antagonizes the growth stimulatory effects of epidermal growth factor (EGF) in human keratinocytes (26) . In contrast, squamous carcinomas are resistant to the effects of TGF-/3. A mammary-derived growth inhibitor has also been described by Bano et al. (27) . Mammary cells are responsive to numerous hormones and growth factors. One major question is whether these hormones and growth factors operate directly on the epithelial cell or locally through nonepithelial cells in the mammary fat pad (28) (29) (30) (31) . Irrespective of the mechanism, there are several growth factors that are important mammary mitogens. Using slow-release pellets implanted in the mammary gland, TGF-a (32), EGF (32), 170-estradiol (31) and cholera toxin (33) have been demonstrated to stimulate mammary ductal growth locally. This in vivo technique along with the in vitro culture conditions described by Nandi and co-workers (28, 34) provide excellent tools to evaluate, in a systematic fashion, the responsiveness of mammary preneoplasias and neoplasias to these factors. Thus, the regulation of growth by hormone and growth factors offers a potentially fruitful area for experimentation. Likewise, the expression of specific protooncogenes has been examined only in a cursory fashion.
I have stressed alterations in local growth factors rather than the classical reproductive hormones because many of the mammary preneoplasias (and neoplasias) seem to be ovarian hormone independent for growth, yet retain hormone responsiveness for functional differentiation (these lesions are dependent upon prolactin for growth). Thus, the expression of hormone independence is probably a secondary or coincidental event and not an essential characteristic of these preneoplasias. The relationship of the differentiated state of the preneoplasia to its altered growth potential is an intriguing question. The morphological phenotype of the preneoplastic HOG is alveolar, which represents the differentiated mammary cell expressed in the hormone-stimulated mouse. However, the HOG lines maintain the differentiated phenotype in the hormonal milieau of the virgin mouse. Indeed, the HOG lines are ovarian independent for morphogenesis and for growth, but the cells remain hormonally responsive for casein and a-lactalbumin production, the milk proteins expressed by mammary differentiated cells. It is evident that the preneoplasias are not terminally differentiated, although they exhibit many but not ah 1 the hallmarks of the lactating cell. So far, the expression of whey acidic protein has been difficult to detect in HOG transplants.
The preneoplastic mammary cells seem to represent a cell state similar to that described by Scott and co-workers (35, 36) in the 3T3-adipocyte system. In that system, 3T3 cells differentiate into two cell states: terminally differentiated cells and nonterminally differentiated cells. The latter cell state can re-enter the proliferation cycle. Both 3T3-cell states synthesize a full complement of products typical of differentiated adipocytes and cannot be distinguished cytologically or biochemically. Preneoplastic mammary cells seem to represent a nonterminally differentiated population. So far, the stimulation of casein and a-lactalbumin production in the majority of cells has not been sufficient to alter the tumorigenic potential of the population. The simplest interpretation of the relationship between the alveolar phenotype and preneoplasia would be that the HAN population represents transformation of an alveolar or an alveolar-progenitor cell. Alterations in ovarian dependence are not obligatory for a preneoplastic state. As suggested originally by DeOme et al. (37) and reasserted recently (38) , the characteristics of ovarian hormone indepen-dence and tumorigenic potential are independently assortable characteristics.
New approaches to define the preneoplastic state
There has been a substantial amount of research attempting to define a set of morphological, biochemical, cytological or in vitro growth markers for the mammary preneoplastic state (7, 21, 22, 39, 40) . While these studies have served to define the preneoplastic state as astonishingly similar to pregnant or lactating mammary tissues the majority have not as yet provided positive information on specific alterations underlying the preneoplastic state. (44) have described two monoclonal antibodies to keratin or keratinrelated epitopes which distinguish the three phenotypic stages observed in mammary gland transformation. So far, the specific keratin epitopes recognized by the antibodies have not been clarified. In a related development, Yuspa and Roop (45) have prepared antibodies to keratins which distinguish mammary adenocarcinomas from normal and preneoplastic mammary cells. Their antibodies detect preferential expression of specific keratins in mammary adenocarcinomas. These keratins are expressed in the normal mammary gland only in the stem cells comprising the end bud. Additionally Mackie et al. (46) , using antiserum to tenascin, have demonstrated that tumors but not preneoplasias elicit expression of tenascin in stromal cells surrounding the transformed cells. Tenascin expression appears to be a stromal marker for carcinomas in the mammary gland of the mouse, rat and human. Interestingly, this stromal marker is expressed in the normal mammary gland only during early development of the mammary bud. The similarity in epithelial keratin and stromal tenascin expression between cells of neoplasms and cells in early mammary duct development suggests that neoplastic cells are expressing genes characteristic of an early development state. The common gene expression may be attributed to either deregulation of gene expression in normal adult differentiated mammary cell or the transformation of a specific stem (multipotent) cell resident in the mammary gland. Stem cells have been postulated to exist in the mammary end bud (47, 48) . In the adult mammary gland and in preneoplasias, they have been postulated to exist as isolated 'pale' cells in the luminal compartment of the duct or alveolus (49) . These three examples probably represent secondary changes occurring in neoplastic cells. However, the use of highly sensitive immunohistochemical methods allows the detection of tumor cells emerging from a preneoplastic population. The use of antibodies to a variety of proteins might provide a useful tool to detect preneoplastic and neoplastic cells at very early stages in their progression. An example of such antibodies is the set described by Sonnenberg et al. (50, 51) which were raised against proteins found on mammary cells. A study of expression of these antigens in preneoplasias and neoplasias is in the early stages.
Altered expression of specific cytological or cell-surface proteins
There are three recent experimental approaches which might provide information on molecular alterations associated with the essential biological characteristics of the preneoplastic and neoplastic states. Alterations in cell surface proteins (as defined by lectin-binding sites) and in cytoskeletal proteins have been associated with neoplastic transformation. Mammary preneoplasias do not exhibit alterations in lectin-binding sites (41), although the differential expression of cytoskeletal keratin proteins may provide markers useful to distinguish between the three phenotypicstages. The general pattern of keratin expression is similar in normal, preneoplastic and neoplastic mammary cells whether they are grown in vivo or in vitro (42,43) but Asch and Asch
Development of in vitro culture conditions
A second approach to define the preneoplastic state is the use of in vitro culture conditions. The original experiments were disappointing because the growth characteristics of normal, preneoplastic and neoplastic mouse mammary cells in monolayer cell culture were very similar (21, 39) . However, the experiments of Pitelka and co-workers (52,53), on the culture conditions necessary for mammary cells to exhibit mammary specific functions, provided the basis for explaining the negative results of the original experiments. Basically, mammary cells need to grow and/or interact in a three-dimensional culture condition in order to exhibit mammary specific function. Thus, the experiments where mammary cells were grown on floating collagen gels in the presence of hormones allowed mammary cells to exhibit functional differentiation (i.e. milk-protein synthesis). Subsequent experiments demonstrated that the position of the cells and the nature of the substratum (on top of collagen versus embedded within collagen; collagen versus collagen-laminin-proteoglycan gel) allowed more complete expression of differentiated function (28, 34, (54) (55) (56) (57) (58) .
The second breakthrough was the development of culturing normal mammary cells in a serum-free medium in collagen gels (28, 59 ). This achievement not only will allow a comparative analysis of the growth requirements for the three phenotypic stages, but has allowed chemical-carcinogen-induced transformation of normal mammary cells (60) . The transformants gave rise to alveolar and ductal hyperplasias as well as neoplasias when the cells were transplanted into gland-free fat pads. The importance of these two methodological achievements cannot be overemphasized because they provide the appropriate conditions to examine the hormonal (growth factor) regulation of differentiation and transformation. Furthermore, the conditions are now available to examine questions concerning the interactions among cell type, hormones, growth-factor dependency and protooncogene expression in successive stages of the neoplastic transformation. Such experiments in the rat mammary-tumor system have recently been published by Ethier and Cundiff (61) . They have defined two subsets of DMBA-induced mammary tumors. One subset is growth-factor dependent for in vitro cell culture growth and produces normal mammary parenchyma in vivo. The other subset is growth factor independent for in vitro cell culture growth and produces tumors in vivo. The primary tumors in situ were not distinguishable by any obvious criteria. The culture conditions used by Ethier and Cundiff were collagen-coated dishes.
Other culture systems have been defined which are variants of the three-dimensional concept and provide some unique advantages. Mammary cells grown on feeder layers of 3T3-L1 cells (62, 63) and LA-7 (64) rat carcinoma cells provide appropriate substrates to examine differentiation responses. Normal cells grown of LA-7 feeder layer can be subcultured in vitro for 10 passages and can be transplanted in the cleared mammary fat pads up to at least the third in vitro passage. The cells remained diploid at passages 3 and 7. In summary, the questions originally posed 10 years ago regarding the biochemical and molecular basis for the essential growth characteristics of preneoplastic and neoplastic cells can now be addressed using appropriate in vitro culture systems. (73, 77, 78) . In a very rare instance, complete activation leading to virion production can occur (73) . In the BALB/c series of HOG lines, neither the preneoplasias nor tumors derived from them uniformly exhibit expression of the endogenous MMTV genes or contain new provirus integration sites. New proviruses can occur in preneoplasias and tumors, but these are not obligatory for transformation (71, 73, 79) . In instances where new proviruses occurred, the expression of ;'n;-genes was not evaluated. However, the bulk of the data suggest that activation and/or re-integration of endogenous MMTV is not necessary for either preneoplastic development, tumor development from preneoplasias or development of DMBA-induced tumors. When such events are observed one can conclude only that such events may be related to transformation. Definitive causative relationships have yet to be proven.
Molecular alterations in mammary transformation
The relative importance of protooncogene expression in preneoplastic and neoplastic mammary development has only recently been examined, but the available data show intriguing correlations. DMBA activates (mutates) the c-Ha-ras gene in both rat and mouse mammary gland as demonstrated by the NIH3T3 transfection assay (80, 81) . The ras gene was mutated at codon 61 at a high frequency in both animal systems. The original experiment in the mouse system utilized tumors arising from the DI/UCD HOG subline. Spontaneous tumors arose from this subline at a high frequency, but such tumors were negative for c-Ha-ras activation, in contrast to the same tumors induced by DMBA (81) . In a subsequent experiment, the low-tumor incidence C4 HOG line was treated with DMBA. The rare spontaneous tumors and the untreated preneoplasias were negative for c-Ha-ras activation, while the DMBA-induced tumors exhibited a high frequency of c-Ha-ras activation by mutation at codon 61. The DMBA-treated preneoplasias are currently being examined for activation of c-Ha-ras in preneoplastic cells (S.Sukumar and D. Medina, unpublished) . The absence of c-Haras activation in spontaneous mammary tumors contrasts with the situation in spontaneous mouse liver tumors. Two groups have reported activation of c-Ha-ras by mutation at codon 61 in spontaneously occurring hepatocellular carcinomas as well as in benign tumors (82, 83) . The demonstration of ras activation by DMBA and the prior demonstration that tumors arise from preneoplasias in a clonal fashion (84) provide an explanation for why DMBAtreated preneoplasias do not behave homogeneously in transplantation experiments (85) . Previous experiments have shown that subdivision of a DMBA-treated outgrowth into 40 pieces, followed by transplantation into cleared fat pads, resulted in very few tumors, whereas, left untransplanted, each outgrowth eventually would produce a tumor. The frequency of transformed cells, as detected by the transplantation experiments, was directly proportional to the amount of DMBA exposure of the preneoplastic outgrowths (85) . Activation of ras is presumably a rare event, yet once activated results in the development of tumors from the preneoplasias.
It is likely that ras activation is not sufficient for tumorigenesis. The frequency and pattern of tumor development in transgenic mice carrying an MTV-LTR-or WAP-promoter-driven ras transgene suggests that more than one event is needed (86, 87) . Additionally, the experiments of several groups examining tumor suppressor genes (88) (89) (90) (91) (92) suggests that ras activation in addition to one or two other events is necessary for the neoplastic transformation. The mammary gland provides an excellent system to examine the consequence of ras activation since several defined stages can be compared.
The expression of protooncogenes in human breast tumors suggests multiple mechanisms occur in neoplastic development within a common tumor phenotype. For instance, elevated levels of neu have been described in human breast tumors (93, 94) . The enhanced expression of neu correlates with a poor prognosis for recurrence and survival in node-positive breast cancer (95, 96) . The expression of ras protein (p21) has been found in increased levels in tumors when compared with their normal cell counterparts by immunohistochemistry. At the present time, there are conflicting results on the association of p21 ras expression with proliferation and malignancy (97) (98) (99) . Clair et al. (97) reported a positive correlation between increased expression of p21 ras and the progression of breast cancer. In contrast, Chesa et al. (98) reported a lack of association between p21 ras expression and proliferation and malignancy. Horan-Hand et al. (99) noted elevated levels of p21 ras in breast cancers compared with normal tissue, but increased levels were also detected in dysplastic lesions. There was no consistent correlation observed between primary and metastatic tumors in the levels of p21 protein, a result which confirmed earlier experiments (100,101). Horan-Hand et al. (99) concluded elevated levels of p21 ras were not necessary to maintain the neoplastic state. So far, the quantitative analysis of protooncogene RNA and protein in normal, dysplastic and neoplastic development of the breast has not been extensive or precise enough to allow firm interpretations. In murine models, this question can be examined more precisely. An initial study on the expression of a battery of protooncogenes in preneoplastic HOG line Dl and tumors derived from its detected elevated expression (2-6X) of c-Ha-ras and c-Ki-ras RNA in tumors com-pared with the preneoplasias (19) . The levels of these RNAs in preneoplasias were not increased compared with that seen in normal pregnant mammary gland. In general, the levels of c-fos, c-myc, \-sis, \-abl, \-jps, \-ros, int-l and int-2 were not consistently increased in tumors compared with preneoplasias, although elevated levels of \-abl and v-fps were seen in a few tumors. Amplification of neu DNA was not detected by Southern analysis. Given the homogeneity of the preneoplastic population, it is evident that multiple mechanisms may result in a similar neoplasm.
The intriguing observation was the frequent elevation in expression of ras. The insertion of ras as a transgene illustrates that increased expression of the gene can lead to a high frequency of mammary tumorigenesis (86) . However, in another strain of mice, ras as a transgene was a weak oncogene (87) . Clearly, multiple factors are involved in regulation of tumorigenesis, as has been documented by numerous investigators in other systems (92) . One method to examine the consequences of protooncogene expression is transfection of appropriate target cells. Several experiments have demonstrated that transfection of oncogene DNA into preneoplastic mammary cell lines leads to the formation of neoplasms. For instance, transfection of v-Ha-ras and \-fgr oncogenes into the cell line COMMA-D (clone 14) resulted in anchorage-independent growth in vitro and induction of tumors in vivo by the transfected cells, whereas addition of v-wyc resulted in the same cells acquiring only anchorage-independent growth (102) . In addition, oncogene expression altered cytoskeletal expression, morphogenesis and hormone responsiveness in vitro in unique ways, v-myc-expressed COMMA-D cells displayed a decreased synthesis of cytokeratin and increased levels (X10) of /3-casein mRNA and protein in response to hormones. Transfection of v-Ha-ras in the mouse cell line NMuMG resulted in a decreased responsiveness of the cells to EGF and an increased production of TGF-a (103). A similar result was reported for v-ras-transfected MCF-7 human tumor cells (104).
Perspectives
The above results are exciting but should be viewed with caution. The critical experiments need to address not what a particular oncogene can do in an established cell line (tumor or non-tumorigenic line) but what an oncogene actually does in mammary transformation. Firstly, it will be important to determine which oncogenes are expressed during mammary preneoplastic, and neoplastic transformation in vivo, in order to select the relevant genes to examine by transfection. Secondly, it will be important to transfect mammary cells under conditions in which the cells retain morphogenic and functional properties. Thus, the task will be to transfect normal mammary cells and preneoplastic cells (or cell lines) which retain mammary specific morphogenic properties. So far, no one has successfully transfected normal mammary cells. However, the new cell culture methodology developed by Nandi and co-workers (28, 34, 59, 60) provides the possible means to achieve these ends. It should be feasible to determine if transfection of normal mammary cells by \-ras, int-1 or erb-B results in neoplasias or cells with altered growth factor dependencies in vivo or in vitro. Similarly, questions regarding the expression of protooncogenes after DMB A treatment and the consequences of such events could be addressed. Finally, the role of particular oncogenes (or protooncogenes) in each stage of mammary transformation can be examined.
It would appear that the methods are finally available to address fundamental questions at the molecular basis to understand the behavioral properties that are so well defined biologically in preneoplastic and neoplastic murine mammary development. A concerted effort on such questions should provide fundamental knowledge applicable to understanding the cancer problem in all epithelial systems.
